Combodart product overview
What is Combodart?
Combodart is a fixed dose combination therapy, indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH), and the reduction in the risk of acute urinary retention (AUR) and surgery in patients with moderate to severe symptoms of BPH.
In adults (including elderly), the recommended dose of Combodart is one capsule (0.5 mg/ 0.4 mg) once daily.
AB: Last Updated January 2017: MLT_GIB/OTH/0001/15c(1)